Tag Archives: medical devices

Medical Device Investors Share Their Expert Advice at RESI San Diego

25 May

By Lucy Parkinson, Director of Research, LSN

The medical device industry is consolidating rapidly, and many entrepreneurs find the medtech fundraising landscape challenging to navigate.  However, there are a great diversity of early stage device investors out there looking for deals. This RESI panel brings together device investors from US and international VCs, a major device firm, and a private investment group to discuss how they assess medical device opportunities, and how an entrepreneur can build a productive dialogue with their firm.

Moderated by David Cassak (CEO, Innovation In Medtech), the panelists are:

Tags: , , , ,

Hot Life Science Investor Mandate 3: VC Fund Looking Opportunistically in the Life Sciences

10 Jul

A Venture Capital company with offices in the Eastern and Western United States is looking to make equity investments ranging from approximately $3-$5 million initially and $10-$25 million over the investment’s lifetime. The firm looks for companies primarily in the United States, and some select opportunities in Europe. The firm plans to make between 1-5 investments over the next year.

The firm is interested in sectors of Biotech Therapeutics, Diagnostics, Medical Devices, Life Science Tools and Healthcare IT. In the Therapeutics space the firm is looking for both small molecule and biologics that are 1 year from entering clinical trials or later with a preference for companies that have in human data. The firm is generally open to all indications but is especially interested in areas of Oncology, Immunology and Orphan Diseases. For Medical Devices, Diagnostics and Life Science Tools the firm prefers to make later stage investments into companies that have significant in human data or have already been commercialized.

The firm is looking for experienced management teams and generally requires a board seat. The firm looks to take company through significant value inflection points acting as a very hand on investor. The firm almost always leads or co-leads investment rounds.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Tags: , , , , ,

Hot Life Science Investor Mandate 1: Singapore VC Fund Looking to Help Companies Expand to Asia

3 Jul

A venture capital firm based in Singapore is looking to make early, growth, expansion, and mezzanine stage investments in the healthcare sector. The firm typically invests in the Series A and B rounds. The firm has raised two funds to date. The firm seeks to invest in non-Asian companies that are interested in entering the Asian market; investment funds are prioritized to companies looking to set up operations in Singapore. The firm will also invest in companies based in Asia. The investment size is variable depending on the stage of the company; ranging from $1M to $10M or more. The firm will consider opportunities from around the globe and is actively seeking new investment opportunities. 

The firm seeks to invest in biopharmaceuticals, diagnostics, and medical devices. For therapeutics, the firm prefers novel small molecules and biologics targeting indications in large markets. The firm prefers to invest in platform technologies and typically invests in clinical stage opportunities. For medical devices, the firm prefers devices in the later stages of development or near commercialization. The firm seeks a strong management team and considers both private and public companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Tags: , , , , , , ,

Hot Life Science Investor Mandate 1: Multi-Family Office Rapidly Making New Allocations

9 Jan

Allocation Information

A multi-family office based in the Western US is an active investor in the medical device sector, and is interested in opportunities worldwide.  Initial investments are typically about $50,000 with the potential for follow-on investments totaling $500,000, and may be structured as equity or as debt.  The office does not invest in seed rounds.  In the recent past the office has allocated new investments at a rate of approximately one per month.  The firm offers support and expertise to portfolio companies but does not seek a board seat.

Sectors & Subsectors of Interest

Within the medical device sector, only devices with a basis in mechanical engineering, such as electro-mechanical medical devices, active implantable devices such as pacemaker technologies, and surgical instruments are of interest.  The family office invests only in companies that have already developed a prototype of their product and filed a patent application; the firm prefers that companies that seek an allocation have in-human data but does not require this.

Company & Management Team Requirements

The family office seeks to invest in strong management teams with prior experience in the medical device industry, preferably with previous successful exits and with a strong reputation in their niche.  The firm invests only in privately-held companies and prefers to make investments with the potential to exit within 3-4 years.

Tags: , , , ,

Hot Life Science Investor Mandate 3: Opportunistic European VC Actively Seeking New Investments

6 Nov

A venture capital firm with several offices worldwide is based primarily in Europe, and co-manages an early-stage fund focused on academic spinouts and seed investments in Europe. The firm has approximately €500M AUM, and is currently managing four active funds. The firm makes equity investments in life science and biomedical technology companies at all stages of development. However, the VC prefers late stage preclinical or early stage clinical for therapeutics and diagnostics and medical devices that are close to market approval. The typical investment per round is €3M to €7M. The firm looks for companies that are based in the US, Canada, and Europe. They are actively screening new investment opportunities.

This group is fairly opportunistic in the life sciences space, but generally targets therapeutics and diagnostics, medical devices, and biopharmaceuticals. In therapeutics, the firm focuses on drug development and has no specific preference in indication. In medical devices, they have a special focus on interventional devices in cardiology, gastroenterology and pulmonology that are close to or on the market approval. However, the firm is equally opportunistic in other subsectors and indications for medical devices, but all with a therapeutic focus.

The VC invests in companies at all stages of their development. For drug development, they invest from late preclinical to mid-stage clinical development. Sometimes they will consider companies with products on the market. The firm seeks a company with a strong and experienced management team or technical experts in the relevant technology.

Tags: , , ,

Newer Entries →